Epstein-Barr virus encephalitis in a renal allograft recipient diagnosed by polymerase chain reaction on cerebrospinal fluid and successfully treated with ganciclovir.
MacGinley
R
R
Bartley
P B
PB
Sloots
T
T
Johnson
D W
DW
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D004279:DNA, Viral / Q000134:cerebrospinal fluid / Q000235:genetics; D018792:Encephalitis, Viral / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D020031:Epstein-Barr Virus Infections / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D005260:Female; D015774:Ganciclovir / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D016030:Kidney Transplantation / Q000009:adverse effects*; D016853:Muromonab-CD3 / Q000009:adverse effects; D016133:Polymerase Chain Reaction
D000998:Antiviral Agents; D004279:DNA, Viral; D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D015774:Ganciclovir